🇺🇸 FDA

Company profile · Sponsor

Biohaven

Biohaven Bioscience Ireland Limited

E85CDC5 · EMA pharma GB
Pipeline
6
Drugs
0
Patents
0

Quick answer

Biohaven (E85CDC5) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E85CDC5
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (6)

Search pipeline →

  1. BHV-7000, Placebo for BHV-7000, BHV-7000

    Biohaven

    Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures

    phase 3 small molecule active

    1 trial

  2. BHV-8000, DaTSCAN 74 MBq/ml solution for injection, DaTSCAN 74 MBq/ml solution for injection, BHV-8000, Placebo for BHV-8000

    Biohaven

    Early Parkinson’s Disease

    phase 3 small molecule active

    1 trial

  3. Placebo for BHV-7000, Placebo BHV-7000, BHV-7000, BHV-7000

    Biohaven

    Refractory Focal Onset Epilepsy

    phase 3 small molecule active

    1 trial

  4. BHV-7000, BHV-7000

    Biohaven

    Refractory Focal Onset Epilepsy

    phase 2 small molecule active

    1 trial

  5. BHV-7000, BHV-7000, Placebo for BHV-7000

    Biohaven

    Refractory Focal Onset Epilepsy

    phase 2 small molecule active

    1 trial

  6. A study to determine if BHV-2100 and BHV-7000 are effective, safe, and tolerable as a pain medication in healthy male participants

    Biohaven

    Pain

    phase 1 other active

    1 trial

Frequently asked questions

What is Biohaven?

Biohaven (E85CDC5) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Biohaven sponsor?

We track 6 ClinicalTrials.gov-linked programs for Biohaven, including BHV-7000, Placebo for BHV-7000, BHV-7000 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Biohaven company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.